Skip to content

Stock Market Live 22/10 – Gilead Stock Climbs After FDA Approves Remdesivir

Sam Boughedda
Sam Boughedda trader
Updated 22 Oct 2020

Open Demo Account YOUR CAPITAL IS AT RISK. 68% OF RETAIL CFD ACCOUNTS LOSE MONEY
Sam Boughedda
Sam is a trader and lead stock market writer at AskTraders. After starting his career in the forex market, Sam now focuses on stocks, specifically consumer staples.